Skip to content

Werewolf Therapeutics, Inc.

HOWL· NasdaqCore metricsCIK 1785530

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · +0.86%
Market cap
$48.27M
48.6M shares
Filings
457
—
—
—
-$9.88M
Q3 2026N/M FY25 yoy
-$10.05M
Q3 2026N/M FY25 yoy
-$60.29M
FY 2025derivedN/M FY25 yoy
-$0.20
Q3 2026N/M FY25 yoy
$41.87M
Q3 2026−48.6% FY25 yoy
$48.27M
—
—
7.1×
-124.90%
—

FY2025 figures · derived

Price

$0.993312.10%$0.1367past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$44.83MFY 2025
$56.43M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$44,830,000reported
FY 20242024-12-31$56,434,000reported
FY 20232023-12-31$41,776,000reported
FY 20222022-12-31$53,761,000reported
FY 20212021-12-31$35,269,000reported
FY 20202020-12-31$16,641,000reported

Pharmaceutical preparations

Werewolf Therapeutics, Inc. is the 335th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Werewolf Therapeutics, Inc. · CIK 1785530 · Engraved from SEC EDGAR